Pre-profiling – prospectively stratifying patients through genomic screening – was developed to provide value to patients via access to rapid, broad-based genomic testing of their cancer and to drive value to clinical study sponsors through faster recruitment of niche patient populations. Pre-profiling is a core component of Quintiles Precision Enrollment, which connects the right patient to the right trial quickly.